Remedium Lifecare [REMLIFE] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Remedium Lifecare Ltd.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Remedium Lifecare Ltd. wins in 6 metrics, Innova Captab Ltd. wins in 13 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Remedium Lifecare Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 6.54 31.20 Remedium Lifecare Ltd.
Price-to-Book Ratio 0.71 4.05 Remedium Lifecare Ltd.
Debt-to-Equity Ratio 1,033.81 32.95 Innova Captab Ltd.
PEG Ratio 0.03 1.33 Remedium Lifecare Ltd.
EV/EBITDA 206.57 20.49 Innova Captab Ltd.
Profit Margin (TTM) 2.33% 8.85% Innova Captab Ltd.
Operating Margin (TTM) 6.64% 12.88% Innova Captab Ltd.
EBITDA Margin (TTM) 6.64% 12.88% Innova Captab Ltd.
Return on Equity 16.22% 13.37% Remedium Lifecare Ltd.
Return on Assets (TTM) 0.19% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $-11.44B $-1.09B Innova Captab Ltd.
Dividend Yield N/A 0.30% N/A
1-Year Return -78.03% -3.19% Innova Captab Ltd.
Price-to-Sales Ratio (TTM) 0.14 2.76 Remedium Lifecare Ltd.
Enterprise Value $11.62B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 2.21 2.90 Remedium Lifecare Ltd.
Gross Profit Margin (TTM) 9.53% 35.19% Innova Captab Ltd.
Revenue per Share (TTM) $8 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $0.13 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 1.04 -0.33 Innova Captab Ltd.

Remedium Lifecare Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

REMLIFE
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Remedium Lifecare Ltd.-2.78%-5.41%-20.45%-30.00%-65.35%-53.33%
Innova Captab Ltd.-0.58%2.60%3.33%34.84%22.58%18.16%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Remedium Lifecare Ltd.-78.03%-97.95%-55.81%245.45%245.45%245.45%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Remedium Lifecare Ltd. vs Innova Captab Ltd.

MetricREMLIFEINNOVACAP
Market Information
Market Cap i₹308.70M₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i13,880,489578,151
90 Day Avg. Volume i13,121,813217,693
Last Close₹0.35₹867.50
52 Week Range₹0.32 - ₹1.80₹622.00 - ₹1,020.70
% from 52W High-80.56%-15.01%
All-Time High₹4,547.80 (Jul 03, 2023)₹1,260.00 (Jan 06, 2025)
% from All-Time High-99.99%-31.15%
Growth Metrics
Quarterly Revenue Growth3.43%0.42%
Quarterly Earnings Growth3.86%0.23%
Financial Health
Profit Margin (TTM) i0.02%0.09%
Operating Margin (TTM) i0.07%0.13%
Return on Equity (TTM) i0.16%0.13%
Debt to Equity (MRQ) i1,033.8132.95
Cash & Liquidity
Book Value per Share (MRQ)₹1.19₹178.28
Cash per Share (MRQ)₹0.02₹10.22
Operating Cash Flow (TTM) i₹-9,983,884,288₹282.88M
Levered Free Cash Flow (TTM) i₹-9,656,687,616₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend iN/A₹2.00

Valuation & Enterprise Metrics Analysis: Remedium Lifecare Ltd. vs Innova Captab Ltd.

MetricREMLIFE (Mar 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i6.5431.20
Forward P/E iN/A21.90
PEG Ratio i0.031.33
Price to Sales (TTM) i0.142.76
Price to Book (MRQ) i0.714.05
Market Capitalization
Market Capitalization i₹308.70M₹41.43B
Enterprise Value i₹11.62B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i2.212.90
Enterprise to EBITDA i206.5720.49
Risk & Other Metrics
Beta i1.04-0.33
Book Value per Share (MRQ) i₹1.19₹178.28

Financial Statements Comparison: Remedium Lifecare Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricREMLIFE (2025)INNOVACAP (2025)
Revenue/Sales i4.05B12.34B
Cost of Goods Sold i3.98B8.38B
COGS % of Revenue i98.2%67.9%
Gross Profit i71.16M3.96B
Gross Margin i1.8%32.1%
Research & Development iN/AN/A
Operating Income (EBIT) i12.30M1.65B
Operating Margin i0.3%13.4%
EBITDA i120.41M2.00B
EBITDA Margin i3.0%16.2%
Pre-Tax Income i43.84M1.71B
Pre-Tax Income % of Revenue i1.1%13.9%
Income Tax i22.55M427.58M
Income Tax % of Revenue i0.6%3.5%
Net Income (Profit) i21.29M1.28B
Profit Margin i0.5%10.4%

Balance Sheet & Liquidity Metrics

MetricREMLIFE (2025)INNOVACAP (2025)
Cash & Equivalents i2.82M155.19M
Total Current Assets i17.20B7.03B
Total Current Assets % of Revenue i424.5%57.0%
Total Current Liabilities i16.76B3.53B
Total Current Liabilities % of Revenue i413.7%28.6%
Long-Term Debt i02.45B
Long-Term Debt % of Revenue i0.0%19.8%
Total Shareholders Equity i438.91M9.59B
Retained Earnings i35.71M4.53B
Retained Earnings % of Revenue i0.9%36.7%
Property, Plant & Equipment i83,000442.93M

Cash Flow Statement Comparison

MetricREMLIFE (2025)INNOVACAP (2025)
Operating Cash Flow i-16.38B282.88M
Operating Cash Flow % of Revenue i-404.2%2.3%
Capital Expenditures iN/A-1.72B
Free Cash Flow i-11.44B-1.09B
FCF Margin i-282.4%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricREMLIFEINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i881.99M57.22M
Float Shares i382.00M15.91M
% Held by Insiders i15.76%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i84.24%8.59%

Dividend Analysis & Yield Comparison: Remedium Lifecare Ltd. vs Innova Captab Ltd.

MetricREMLIFEINNOVACAP
Last 12-Month Dividend iN/A₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend iN/A₹0.67
3-Year Avg Dividend Yield iN/A0.30%
3-Year Total Dividends iN/A₹2.00
Ex-Dividend DateN/AJan 30, 2026